[Informe de investigación] El mercado de servicios de organizaciones de investigación por contrato (CRO) de atención médica se valoró en 43.208,57 millones de dólares en 2019 y se prevé que alcance los 87.859,08 millones de dólares en 2027; se espera que crezca a una tasa compuesta anual del 9,5% de 2020 a 2027.
La organización de investigación por contrato (CRO) brinda servicios de apoyo a empresas farmacéuticas, de biotecnología y de dispositivos médicos durante todo el desarrollo del producto. Farmacéutica y Las empresas de biotecnología y la industria de dispositivos médicos requieren diversos servicios de pruebas, como servicios preclínicos, servicios de investigación clínica, servicios de pruebas analíticas, servicios de pruebas bioanalíticas y servicios regulatorios. Los CRO están diseñados específicamente para realizar estos servicios de prueba para reducir el costo interno y el tiempo de las empresas, necesarios para realizar la amplia gama de servicios de prueba para cumplir con los estándares regulatorios nacionales e internacionales. El crecimiento del mercado mundial de servicios CRO de atención sanitaria se atribuye al creciente número de ensayos clínicos y al aumento del gasto en I+D y actividades de subcontratación. Sin embargo, la escasez de profesionales capacitados es el factor principal que obstaculiza el crecimiento del mercado de servicios CRO de atención médica
Cobertura del informe
Se espera que el mercado mundial de servicios de organizaciones de investigación por contrato (CRO) de atención médica experimente un crecimiento sustancial después de la pandemia. El COVID-19 ha afectado a las economías e industrias de varios países debido a cierres, prohibiciones de viaje y cierres de empresas. La crisis de la COVID-19 ha sobrecargado los sistemas de salud pública en muchos países y ha puesto de relieve la gran necesidad de realizar inversiones sostenibles en los sistemas de salud. A medida que avanza la pandemia de COVID-19, se espera que la industria de la salud experimente una caída en su crecimiento. El segmento de ciencias biológicas prospera debido a la mayor demanda de productos de diagnóstico in vitro y al aumento de las actividades de investigación y desarrollo en todo el mundo. Sin embargo, el segmento de tecnologías médicas e imágenes está experimentando una caída en las ventas debido a un menor número de cirugías realizadas y a retrasos o prolongaciones en la adquisición de equipos. Además, se espera que las consultas virtuales realizadas por profesionales de la salud se conviertan en el modelo principal de prestación de atención después de la pandemia. Dado que la telesalud está transformando la prestación de atención, la salud digital seguirá prosperando en los próximos años. Además, también se espera que la interrupción de los ensayos clínicos y el consiguiente retraso en el lanzamiento de medicamentos allanen el camino para ensayos totalmente virtuales en el futuro. Se espera que surjan nuevas tecnologías como el ARNm y que cambien la industria farmacéutica y también se espera que el mercado sea testigo de una mayor integración vertical y empresas conjuntas en los próximos años.
regiones lucrativas para el mercado mundial de servicios CRO de atención sanitaria
Perspectivas del mercado
Número creciente de ensayos clínicos para impulsar el crecimiento del mercado mundial de servicios de organizaciones de investigación por contrato (CRO) de atención sanitaria
Los ensayos clínicos desempeñan un papel determinante en la aprobación de medicamentos y su eficacia sobre las enfermedades. Los estudios ayudan a comprender los mejores enfoques médicos en determinadas áreas terapéuticas. Los sistemas de salud de todo el mundo están observando un rápido aumento en el número de ensayos clínicos. Factores como la creciente demanda de nuevos medicamentos y equipos médicos, la creciente prevalencia de enfermedades crónicas y el crecimiento de los programas de financiación para realizar ensayos clínicos son responsables de impulsar el número de ensayos clínicos en todo el mundo.
Además, Muchas de las empresas se centran en establecer asociaciones con organizaciones de investigación por contrato para realizar estudios clínicos de manera eficiente. Por ejemplo, en diciembre de 2019, Cyclo Therapeutics firmó un acuerdo de servicio con Worldwide Clinical Trials, una organización de investigación por contrato para ejecutar proyectos de empresas. programas clínicos, para la evaluación de Trappsol Cyclo un tratamiento para la enfermedad de Alzheimer. Además, en mayo de 2020, Daré; Bioscience, Inc. celebró una asociación estratégica con Health Decisions, Inc., una importante organización de investigación por contrato, para acelerar los estudios clínicos en el marco de programas de salud de la mujer. Este creciente número de colaboraciones eventualmente aumentará la contribución de las organizaciones de investigación por contrato en la ejecución de estudios clínicos, lo que eventualmente impulsará el crecimiento del mercado.
Información basada en el tipo de servicio
En términos de tipo de servicio, el mercado global de servicios de organizaciones de investigación por contrato (CRO) de atención médica se segmenta en desarrollo de fase temprana, servicios de laboratorio, servicios de consultoría y servicios de investigación clínica. En 2019, el segmento de servicios de investigación clínica tuvo la mayor participación del mercado. Además, se estima que el mismo segmento registrará la CAGR más alta durante el período de pronóstico.
Mercado global de servicios de atención médica CRO, por tipo de servicio– 2019 y 2027
Perspectivas basadas en indicaciones terapéuticas
En términos de indicación terapéutica, el contrato sanitario global El mercado de servicios de organizaciones de investigación (CRO) está segmentado en oncología, enfermedades infecciosas, trastornos inmunológicos, enfermedades respiratorias, enfermedades cardiovasculares, trastornos neurológicos y otros. En 2019, el segmento de otros tuvo la mayor participación del mercado. Sin embargo, se estima que el segmento de oncología registrará la CAGR más alta durante el período de pronóstico.
Información basada en el usuario final
En términos de usuario final , el mercado mundial de servicios de organizaciones de investigación por contrato (CRO) de atención sanitaria está segmentado en empresas de dispositivos médicos, empresas farmacéuticas y biofarmacéuticas y otras (institutos académicos). El segmento de empresas farmacéuticas y biofarmacéuticas tuvo la mayor participación de mercado en 2019. Además, se estima que el mismo segmento crecerá al CAGR más alto durante el período de pronóstico.
Información estratégica
Los actores del mercado global de servicios de atención médica CRO están adoptando estrategias de lanzamiento y expansión de productos para satisfacer las cambiantes demandas de los clientes en todo el mundo, lo que también les permite mantener su marca a nivel mundial.
< h3>Mercado global de servicios CRO de atención sanitaria: por tipo de servicio
- Desarrollo en fase inicial
- Estudios de descubrimiento
- Química, fabricación y control
- Servicios preclínicos
- Servicios de laboratorio
- Pruebas bioanalíticas
- Pruebas analíticas
- Consultoría Servicios
- Servicios de Investigación Clínica
- Fase I
- Fase II
- Fase III
- Fase IV
Mercado global de servicios CRO de atención sanitaria: por indicación terapéutica
- Oncología
- Enfermedades infecciosas
- Enfermedades respiratorias
- Enfermedades cardiovasculares
- Trastornos neurológicos
- Otros
Mercado global de servicios CRO de atención sanitaria: por Usuario Final
- Empresas de Dispositivos Médicos
- Compañías Farmacéuticas y Biofarmacéuticas
- Otros (Institutos Académicos)
Mercado global de servicios CRO de atención sanitaria: por Geografía
- América del Norte
- Estados Unidos
- Canadá
- México
< li>Europa - Francia
- Alemania
- Italia
- Reino Unido
- España
- Resto de Europa
- Asia Pacífico (APAC)
- China
- India
- Corea del Sur
- Japón
- Australia
- Resto de APAC
- Medio Oriente y Asia África (MEA)
- Sudáfrica
- Arabia Saudita
- EAU
- Resto de MEA
- Suramérica y Centroamérica (SCAM)
- Brasil
- Argentina
- Resto de SCAM
< /ul> - Charles River Laboratories, Inc.
- Iqvia Inc.
- Laboratory Corporation of America Holdings
- Parexel International Corporation
- Icon Plc
- PRA Health Sciences
- Syneos Health
- Medpace
- Wuxi Apptec
- PPD Inc.
Perfiles de la empresa
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Factors like growing number of clinical trials and increasing expenditure in R&D and outsourcing activities are driving the growth of the market. In addition, rising biosimilars and biologics market are likely to have a positive impact on the growth of the market in the coming years.
The clinical trials cost a median of $41,117 per patient and $3,562 per patient visit. Clinical trial cost varies with the therapeutic area, phase of study and region where the clinical trial is being conducted.
Contract research organization (CRO) provides support services to the pharmaceutical, biotechnology, and medical device companies throughout the development of the product. Pharmaceutical& biotechnology companies and the medical device industry require various testing services such as preclinical services, clinical research services, analytical testing services, bio analytical testing services, and regulatory services. CROs are specifically designed to perform these testing services to reduce the in-house cost and time of the companies, required to conduct the extensive range of testing services to comply with the national and international regulatory standards..
The List of Companies - Healthcare Contract Research Organizations (CRO) Services Market
- Charles River Laboratories Inc.
- IQVIA Inc.
- Laboratory Corporation of America Holdings
- Parexel International Corporation
- Icon Plc.
- Pra Health Sciences
- Syneos Health
- Medpace
- Wuxi Apptec
- PPD Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jun 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jun 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jun 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)